David Croteau

3.2k total citations
44 papers, 2.4k citations indexed

About

David Croteau is a scholar working on Genetics, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Croteau has authored 44 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 9 papers in Epidemiology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Croteau's work include Glioma Diagnosis and Treatment (15 papers), Advanced MRI Techniques and Applications (7 papers) and HIV Research and Treatment (5 papers). David Croteau is often cited by papers focused on Glioma Diagnosis and Treatment (15 papers), Advanced MRI Techniques and Applications (7 papers) and HIV Research and Treatment (5 papers). David Croteau collaborates with scholars based in United States, Canada and Germany. David Croteau's co-authors include Raj K. Puri, John H. Sampson, Tom Mikkelsen, Christoph Pedain, Susan M. Chang, Michael D. Prados, Sandeep Kunwar, Jack Rock, Lisa Scarpace and James L. Fisher and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Neurology.

In The Last Decade

David Croteau

43 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Croteau United States 23 1.0k 677 407 397 344 44 2.4k
Maciej M. Mrugała United States 24 1.3k 1.2× 442 0.7× 462 1.1× 468 1.2× 540 1.6× 91 2.5k
Dennis R. Groothuis United States 36 1.0k 1.0× 852 1.3× 474 1.2× 797 2.0× 451 1.3× 85 3.2k
Kevin Judy United States 34 1.6k 1.6× 1.1k 1.7× 462 1.1× 541 1.4× 428 1.2× 110 3.3k
Herbert H. Engelhard United States 29 1.2k 1.1× 228 0.3× 634 1.6× 759 1.9× 283 0.8× 88 2.8k
Adam M. Sonabend United States 28 1.0k 1.0× 221 0.3× 175 0.4× 750 1.9× 551 1.6× 83 2.5k
Yael Mardor Israel 30 457 0.5× 961 1.4× 143 0.4× 459 1.2× 182 0.5× 71 2.7k
Andreas H. Jacobs Germany 26 1.2k 1.2× 1.1k 1.6× 497 1.2× 759 1.9× 300 0.9× 62 2.9k
Kevin O. Lillehei United States 39 1.8k 1.7× 446 0.7× 833 2.0× 952 2.4× 758 2.2× 145 5.0k
Marie‐Christine Guiot Canada 32 860 0.8× 544 0.8× 341 0.8× 1.4k 3.6× 459 1.3× 100 4.3k
María Martínez-Lage United States 32 1.3k 1.3× 772 1.1× 1.2k 3.1× 604 1.5× 408 1.2× 84 3.4k

Countries citing papers authored by David Croteau

Since Specialization
Citations

This map shows the geographic impact of David Croteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Croteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Croteau more than expected).

Fields of papers citing papers by David Croteau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Croteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Croteau. The network helps show where David Croteau may publish in the future.

Co-authorship network of co-authors of David Croteau

This figure shows the co-authorship network connecting the top 25 collaborators of David Croteau. A scholar is included among the top collaborators of David Croteau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Croteau. David Croteau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Croteau, David, Tiffany Kim, J. Clarke Stevens, et al.. (2024). Progressive multifocal leukoencephalopathy associated with sphingosine-1-phosphate receptor modulators: A large case series. Multiple Sclerosis and Related Disorders. 92. 106163–106163.
2.
Kim, Tiffany, Allen Brinker, David Croteau, et al.. (2023). Immune-mediated colitis associated with ocrelizumab: A new safety risk. Multiple Sclerosis Journal. 29(10). 1275–1281. 9 indexed citations
3.
Kim, Tiffany, David Croteau, Allen Brinker, et al.. (2020). Expanding spectrum of opportunistic infections associated with dimethyl fumarate. Multiple Sclerosis Journal. 27(8). 1301–1305. 5 indexed citations
4.
Anderson, Albert M., David Croteau, Ronald J. Ellis, et al.. (2018). HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau. Journal of Neuroimmunology. 319. 13–18. 21 indexed citations
5.
Ma, Qing, Florin Vaida, David Croteau, et al.. (2015). Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. Journal of NeuroVirology. 22(2). 170–178. 109 indexed citations
6.
Croteau, David, Brookie M. Best, Scott Letendre, et al.. (2012). Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration. AIDS. 26(7). 890–893. 15 indexed citations
7.
Croteau, David, Steven S. Rossi, Brookie M. Best, et al.. (2012). Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration. Journal of Antimicrobial Chemotherapy. 68(3). 684–689. 33 indexed citations
8.
Mikkelsen, Tom, Joe R. Anderson, Thomas J. Doyle, et al.. (2010). Phase I/II dose escalation trial of concurrent temozolomide and whole brain radiation therapy for multiple brain metastasis. Journal of Neuro-Oncology. 100(2). 241–247. 11 indexed citations
9.
Mueller, Sabine, Mei‐Yin C. Polley, Benjamin J. Lee, et al.. (2010). Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study. Journal of Neuro-Oncology. 101(2). 267–277. 54 indexed citations
10.
Kunwar, Sushma, Susan M. Chang, Manfred Westphal, et al.. (2010). Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro-Oncology. 12(8). 871–881. 377 indexed citations
11.
Mikkelsen, Tom, Thomas J. Doyle, John E. Anderson, et al.. (2008). Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma. Journal of Neuro-Oncology. 92(1). 57–63. 30 indexed citations
12.
Vogelbaum, Michael A., John H. Sampson, Sandeep Kunwar, et al.. (2007). CONVECTION-ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN-13-PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS. Neurosurgery. 61(5). 1031–1038. 112 indexed citations
13.
Sampson, John H., Martin Brady, Neil A. Petry, et al.. (2007). INTRACEREBRAL INFUSATE DISTRIBUTION BY CONVECTION-ENHANCED DELIVERY IN HUMANS WITH MALIGNANT GLIOMAS. Operative Neurosurgery. 60(2). 89–99. 112 indexed citations
14.
Sampson, John H., Raghu Raghavan, Martin Brady, et al.. (2007). Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. Neuro-Oncology. 9(3). 343–353. 103 indexed citations
15.
Kioi, Mitomu, Syed R. Husain, David Croteau, Sandeep Kunwar, & Raj K. Puri. (2006). Convection-enhanced Delivery of Interleukin-13 Receptor-directed Cytotoxin for Malignant Glioma Therapy*. Technology in Cancer Research & Treatment. 5(3). 239–250. 53 indexed citations
16.
Croteau, David, Stuart Walbridge, Paul F. Morrison, et al.. (2005). Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer. Journal of neurosurgery. 102(1). 90–97. 44 indexed citations
17.
Escudier, Bernard, Peter Venner, Lee Stern, et al.. (2004). Prognostic factors in metastatic renal cell carcinoma after failure of immunotherapy: Lessons from a large phase III trial. Journal of Clinical Oncology. 22(14_suppl). 4547–4547. 9 indexed citations
18.
Rock, Jack, David Hearshen, Lisa Scarpace, et al.. (2002). Correlations between Magnetic Resonance Spectroscopy and Image-guided Histopathology, with Special Attention to Radiation Necrosis. Neurosurgery. 51(4). 912–920. 166 indexed citations
19.
Batist, Gerald, François Patenaude, David Croteau, et al.. (2002). Neovastat (Æ-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels. Annals of Oncology. 13(8). 1259–1263. 72 indexed citations
20.
Rock, Jack, David Hearshen, Lisa Scarpace, et al.. (2002). Correlations between Magnetic Resonance Spectroscopy and Image-guided Histopathology, with Special Attention to Radiation Necrosis. Neurosurgery. 51(4). 912–920. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026